{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:35:51Z","timestamp":1790764551298,"version":"4.1.0"},"reference-count":20,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,4,1]]},"DOI":"10.1001\/jamaneurol.2020.5407","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T22:22:00Z","timestamp":1612822920000},"page":"426","source":"Crossref","is-referenced-by-count":46,"title":["Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis"],"prefix":"10.1001","volume":"78","author":[{"given":"Tarek","family":"Sharshar","sequence":"first","affiliation":[{"name":"Neuro-anesthesiology and Intensive Care Medicine, GHU-Paris, Sainte-Anne Hospital, Paris-17 Universit\u00e9 de Paris, Paris, France"},{"name":"General Intensive Care Unit, APHP, Raymond Poincar\u00e9 Hospital, University of Versailles Saint-Quentin en Yvelines, Garches, France"},{"name":"Experimental Neuropathology, Infection and Epidemiology Department, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Porcher","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology, Assistance Publique H\u00f4pitaux de Paris, H\u00f4tel Dieu Hospital, University Paris Descartes\u2013France, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Demeret","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neuro-ICU, APHP-Paris-Sorbonne University, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Tranchant","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Gueguen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Rothschild Ophthalmologic Foundation, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Eymard","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neuro-ICU, APHP-Paris-Sorbonne University, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Nadaj-Pakleza","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital, Strasbourg, France"},{"name":"France Department of Neurology, University Hospital, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Spinazzi","sequence":"additional","affiliation":[{"name":"France Department of Neurology, University Hospital, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamiae","family":"Grimaldi","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Ambroise Par\u00e9 Hospital, University of Versailles Saint-Quentin en Yvelines, Boulogne-Billancourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Birnbaum","sequence":"additional","affiliation":[{"name":"Neuromuscular Investigation Centre, Institute of Myology, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Friedman","sequence":"additional","affiliation":[{"name":"General Intensive Care Unit, APHP, Raymond Poincar\u00e9 Hospital, University of Versailles Saint-Quentin en Yvelines, Garches, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Clair","sequence":"additional","affiliation":[{"name":"General Intensive Care Unit, APHP, Raymond Poincar\u00e9 Hospital, University of Versailles Saint-Quentin en Yvelines, Garches, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MYACOR Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Aegerter","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djillali","family":"Annane","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Catherine","family":"Aub\u00e9-Nathier","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Bolgert","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Fleury","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Durand","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marie","family":"Gonnaud","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Goulon-Goeau","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gout","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Lofaso","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Marcel","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Pautot","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Penisson-Besnier","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Prigent","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Rohaut","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Vial","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Weiss","sequence":"additional","affiliation":[{"name":"for the MYACOR Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"noi200101r1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms.","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"issue":"1","key":"noi200101r2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards.","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"issue":"10","key":"noi200101r3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies.","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"issue":"4","key":"noi200101r4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary.","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"noi200101r5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","article-title":"Treatment of myasthenia gravis.","volume":"36","author":"Farmakidis","year":"2018","journal-title":"Neurol Clin"},{"issue":"6","key":"noi200101r6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","article-title":"An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.","volume":"71","author":"Sanders","year":"2008","journal-title":"Neurology"},{"issue":"6","key":"noi200101r7","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis.","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"noi200101r8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis.","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"noi200101r9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.","volume":"15","author":"Pascuzzi","year":"1984","journal-title":"Ann Neurol"},{"issue":"12","key":"noi200101r10","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol"},{"issue":"23","key":"noi200101r11","doi-asserted-by":"publisher","first-page":"e2661","DOI":"10.1212\/WNL.0000000000007600","article-title":"Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.","volume":"92","author":"Howard","year":"2019","journal-title":"Neurology"},{"issue":"2","key":"noi200101r12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3325\/cmj.2009.50.105","article-title":"7th revision of the Declaration of Helsinki: good news for the transparency of clinical trials.","volume":"50","author":"Krleza-Jeric","year":"2009","journal-title":"Croat Med J"},{"issue":"4","key":"noi200101r13","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s004150050585","article-title":"Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis.","volume":"247","author":"Sharshar","year":"2000","journal-title":"J Neurol"},{"issue":"7","key":"noi200101r14","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile.","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"issue":"7","key":"noi200101r15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1468-1331.2010.03017.x","article-title":"Course and prognosis of myasthenia gravis: a systematic review.","volume":"17","author":"Mao","year":"2010","journal-title":"Eur J Neurol"},{"key":"noi200101r16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1196\/nyas.2008.1132.issue-1","article-title":"Response to therapy in myasthenia gravis with anti-MuSK antibodies.","volume":"1132","author":"Evoli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"noi200101r17","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/589841","article-title":"Development and implementation of a double-blind corticosteroid-tapering regimen for a clinical trial.","volume":"2015","author":"Collinson","year":"2015","journal-title":"Int J Rheumatol"},{"issue":"1","key":"noi200101r18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1212\/WNL.0000000000002795","article-title":"A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.","volume":"87","author":"Pasnoor","year":"2016","journal-title":"Neurology"},{"issue":"12","key":"noi200101r20","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.","volume":"39","author":"van Staa","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"noi200101r19","unstructured":"Beat? MG. Phase II trial of rituximab in myasthenia gravis. ClinicalTrials.gov identifier: NCT02110706. Updated March 6, 2020. Accessed December 28, 2020. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02110706"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2775980\/jamaneurology_sharshar_2021_oi_200101_1617209035.41761.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T12:58:31Z","timestamp":1617886711000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2775980"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2020.5407","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}